Regardless of what this poster does or does not understand, there is clearly some disconnect. I think part of the problem is that there are just too damn many shares outstanding, same for AMBS. Of course an RS would solve this but then we all know what often happens then (of course and uplist would help).
So I'm sitting here wondering.. if the market is eventually going to pick up on the fact that TOMDF is bringing in millions when before it was just burning R&D cash... is it time to pick up a few more of these "too damn many" shares under .1?
(1)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links